Insights

A study in Cebu, Philippines, found primary dapsone-resistant leprosy in 3.6% of cases. Most Mycobacterium leprae strains remained susceptible to dapsone, but two showed resistance in mouse models.

Area of Science:

  • Medical Microbiology
  • Tropical Medicine
  • Epidemiology

Background:

  • Leprosy remains a significant public health concern globally.
  • Dapsone has been the cornerstone of multidrug therapy for leprosy.
  • Emergence of drug resistance can compromise treatment efficacy and disease control.

Purpose of the Study:

  • To determine the prevalence of primary dapsone resistance in leprosy patients in Cebu, Philippines.
  • To characterize the susceptibility of Mycobacterium leprae isolates to dapsone.

Main Methods:

  • A survey was conducted to identify leprosy patients in Cebu.
  • Susceptibility testing was performed using mouse models inoculated with Mycobacterium leprae isolates.
  • Minimal effective dose and a 10-fold higher dose of dapsone were administered to mice.

Main Results:

  • The prevalence of primary dapsone-resistant leprosy was estimated at 3.6 per 100 patients.
  • Out of 55 patients, 53 had Mycobacterium leprae fully susceptible to dapsone.
  • Mycobacterium leprae from two patients multiplied in mice receiving the minimal effective dapsone dose; one isolate also multiplied at a 10-fold higher dose.

Conclusions:

  • Primary dapsone resistance in leprosy exists in Cebu, Philippines, at a notable prevalence.
  • While most isolates remain susceptible, the identification of resistant strains necessitates ongoing surveillance.
  • Further research is needed to understand the mechanisms and implications of dapsone resistance in leprosy.

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...